Inventor
CASTRO-PALOMINO LARIA JULIO CESAR
ES18 patents
⚠️ This page may combine multiple inventors who share the name “CASTRO-PALOMINO LARIA JULIO CESAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ORYZON GENOMICS SA
6 patentsUS9670136B2Jun 6, 2017
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
ORYZON GENOMICS SA8 citations83
US9487512B2Nov 8, 2016
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
ORYZON GENOMICS SA8 citations82
US9469597B2Oct 18, 2016
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
ORYZON GENOMICS SA8 citations81
US10329256B2Jun 25, 2019
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
ORYZON GENOMICS SA1 citations72
US10214477B2Feb 26, 2019
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
ORYZON GENOMICS SA1 citations72
US9944601B2Apr 17, 2018
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
ORYZON GENOMICS SA4 citations72
NOVARTIS AG
4 patentsUS10561653B2Feb 18, 2020
5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer
NOVARTIS AG11 citations79
US10933064B2Mar 2, 2021
Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1-yl)pyrimidin-4-amine and new salts
NOVARTIS AG3 citations71
US11078191B2Aug 3, 2021
1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-ol and use thereof in the treatment of cancer
NOVARTIS AG3 citations67
US11654144B2May 23, 2023
Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1- yl)pyrimidin-4-amine and new salts
NOVARTIS AG1 citations60
CASTRO PALOMINO LARIA JULIO CESAR
3 patentsUS8258308B2Sep 4, 2012
Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors
CASTRO PALOMINO LARIA JULIO CESAR5 citations57
US8536165B2Sep 17, 2013
Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors
CASTRO PALOMINO LARIA JULIO CESAR3 citations56
US8691852B2Apr 8, 2014
Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors
CASTRO PALOMINO LARIA JULIO CESAR0 citations46